Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Diagnostic marker for parity.

PROVIDER: PRJEB38073 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR9917560_1.fastq.gz	Fastqsanger.gz
	ERR9917560_2.fastq.gz	Fastqsanger.gz
	ERR9917570_1.fastq.gz	Fastqsanger.gz
	ERR9917570_2.fastq.gz	Fastqsanger.gz
	ERR9917561_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

YangziChen2024 - Metabolic Machine Learning Predictor Model for Diagnosis of Gastric Cancer

Project description:The paper "Metabolomic Machine Learning Predictor for Diagnosis and Prognosis of Gastric Cancer" addresses the need for non-invasive diagnostic tools for gastric cancer (GC). Traditional methods like endoscopy are invasive and expensive. The authors conducted a targeted metabolomics analysis of 702 plasma samples to develop machine learning models for GC diagnosis and prognosis. The diagnostic model, using 10 metabolites, achieved a sensitivity of 0.905, outperforming conventional protein marker-based methods. The prognostic model effectively stratified patients into risk groups, surpassing traditional clinical models. I have successfully reproduced the diagnosis model from the paper. This machine learning-based system differentiates GC patients from non-GC controls using metabolomics data from plasma samples analyzed by liquid chromatography-mass spectrometry (LC-MS). The model focuses on 10 metabolites, including succinate, uridine, lactate, and serotonin. Employing LASSO regression and a random forest classifier, the model achieved an AUROC of 0.967, with a sensitivity of 0.854 and specificity of 0.926. This model significantly outperforms traditional diagnostic methods and underscores the potential of integrating machine learning with metabolomics for early GC detection and treatment.

2024-07-23 | MODEL2407230001 | BioModels

Homo sapiens

Project description:Diagnostic marker for lung cancer through microarray analysis

| PRJNA140867 | ENA

Homo sapiens

Project description:Pancreatic cancer cell exosomal microRNA as diagnostic marker

| PRJNA218118 | ENA

Search for a novel diagnostic marker for liver cancer.

Project description:Search for a novel diagnostic marker for liver cancer.

| PRJNA668068 | ENA

Search for a novel diagnostic marker for liver cancer.

Project description:Search for a novel diagnostic marker for liver cancer.

| PRJNA481878 | ENA

O-glycoproteomic datasets on the serum samples from healthy individuals

Project description:Clinical O-glycoproteomics for the development of diagnostic marker for colorectal cancer based on changes in O-glycosylation of serum protein.

2023-07-13 | PXD035280 | JPOST Repository

O-glycoproteomic datasets on the serum samples from patients with colorectal cancer

Project description:Clinical O-glycoproteomics for the development of diagnostic marker for colorectal cancer based on changes in O-glycosylation of serum protein.

2023-07-13 | PXD035279 | JPOST Repository

Effect of acute ischemia stroke on circular RNAs

Project description:To explore circulating circRNAs associated with acute ischemia stroke(AIS), their utility as an early diagnostic marker and their significance in predicting stroke outcomes.

2020-11-04 | GSE133768 | GEO

Regulation of the DNA damage response and melanoma susceptibility by NCOA3

Project description:NCOA3 has important roles in melanoma as a potential diagnostic and susceptibility marker, and as a target for therapy

2021-03-31 | GSE156062 | GEO

Dynamic expression of smRNA from fecal exosome in disease progression of an inflammatory bowel disorder mouse model

Project description:Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract affecting over 3 million adults in the United States. Despite being widespread, reliable early diagnostic tests are not available. In order to remedy this, we examined exosomal small RNA (smRNA), specifically targeting microRNA (miRNA) and piRNA from the stool samples of IBD model mice, interleukin 10 knockout mice (IL-10 KO), as a potential diagnostic marker. Stool samples were specifically chosen because they are readily available and collection is noninvasive.

2023-02-19 | GSE167239 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data